Fair Value Measurements (Tables)

12 Months Ended

Jul. 31, 2024

Fair Value Disclosures [Abstract]

Schedule of Derivatives on Balance Sheet

The fair value of the Company’s derivative contracts, recorded on the Consolidated Balance Sheets, was as follows (in millions):

		Assets				Liabilities
		July 31,				July 31,
	Balance Sheet Location	2024		2023		2024		2023
Designated as hedging instruments
Foreign currency forward contracts	Other current assets, other current liabilities	$	0.1	$	0.6	$	—	$	0.1
Net investment hedges	Other current assets, other long-term assets	3.7		3.6		—		—
Total designated		3.8		4.2		—		0.1
Not designated as hedging instruments
Foreign currency forward contracts	Other current assets, other current liabilities	1.0		0.7		0.3		1.4
Total not designated		1.0		0.7		0.3		1.4
Total		$	4.8	$	4.9	$	0.3	$	1.5

Schedule of Company’s Contingent Consideration Obligations

A reconciliation of the fair value of the Company’s contingent consideration liability that use unobservable inputs was as follows (in millions):

Balance as of July 31, 2023	$	25.0
Issuances	1.0
Settlements	(2.0)
Adjustments to fair value	(2.2)
Balance as of July 31, 2024	$	21.8
Maximum potential payout	$	29.7

Balance as of July 31, 2022	$	24.7
Issuances	—
Adjustments to fair value	0.3
Balance as of July 31, 2023	$	25.0
Maximum potential payout	$	30.7